# Novo Nordisk (Mexico) > organization **Wikidata**: [Q100956116](https://www.wikidata.org/wiki/Q100956116) **Source**: https://4ort.xyz/entity/novo-nordisk-mexico ## Summary Novo Nordisk (Mexico) is a business organization and subsidiary of the global pharmaceutical company Novo Nordisk, established in 1923 and headquartered in Mexico City. It operates as a commercial entity within the Mexican market, functioning as a juridical person under the broader classification of a business undertaking professional and industrial activities. ## Key Facts * **Entity Type:** Business (subclass of organization, economic entity, and juridical person). * **Parent Organization:** Novo Nordisk. * **Inception Date:** 1923. * **Headquarters Location:** Mexico City, Mexico (Coordinates: 19.438746, -99.205559). * **Country of Operation:** Mexico. * **Official Website:** https://www.novonordisk.com.mx/. * **Research Organization Registry (ROR) ID:** 03w48ac58. * **Global Research Identifier (GRID) ID:** grid.508745.b. * **Scilit Organization ID:** 98347. * **Wikidata Description:** Organization. * **Classification:** Instance of "business" and "organization." ## FAQs **When and where was Novo Nordisk (Mexico) established?** The organization was founded in 1923 and is headquartered in Mexico City, the capital and largest city of Mexico. Its physical location is situated at latitude 19.438746 and longitude -99.205559. **What is the corporate structure and parentage of this entity?** Novo Nordisk (Mexico) is a part of the larger Novo Nordisk group, operating as a specific business unit within the country. It is legally classified as a business, which is a type of organization and economic entity. **How can researchers and institutions identify this organization digitally?** The entity is uniquely identified by several persistent identifiers, including ROR ID 03w48ac58, GRID ID grid.508745.b, and Scilit Organization ID 98347. These identifiers link the organization to global research databases and knowledge graphs. **What is the primary function and legal nature of the organization?** As a business, its primary function is to undertake commercial, industrial, or professional activities with the goal of generating profit. Legally, it operates as a juridical person, distinct from but related to concepts like "company" or "trading business." ## Why It Matters Novo Nordisk (Mexico) serves as a critical operational node for the global pharmaceutical industry within the North American market. By establishing a presence in Mexico City since 1923, the entity facilitates the delivery of healthcare solutions and professional services to the Mexican population. Its existence as a formal business entity provides the legal and structural framework necessary for economic activity, wealth creation, and the mobilization of human capital and property in the region. As a subsidiary of Novo Nordisk, it contributes to the broader mission of the parent company while adhering to local commercial regulations and economic standards. ## Notable For * **Longevity:** Operating continuously since its inception in 1923, making it a long-standing entity in the Mexican pharmaceutical sector. * **Global Integration:** Serving as a direct part of the Novo Nordisk corporate structure, linking local operations to a global network. * **Digital Traceability:** Possessing a robust set of persistent identifiers (ROR, GRID, Scilit) that ensure its accurate representation in academic and research databases. * **Strategic Location:** Being headquartered in Mexico City, a major economic and political hub in North America with a population of over 9 million. * **Legal Status:** Functioning as a recognized juridical person and economic entity under Mexican law. ## Body ### Corporate Identity and Classification Novo Nordisk (Mexico) is defined as a business, which is an organization undertaking commercial, industrial, or professional activity. In the hierarchy of organizational types, it is a subclass of "organization," "economic entity," and "juridical person." It is specifically an instance of the "business" entity type, distinct from related concepts such as "business activity" or the academic subject area of business. The organization operates with the primary goal of generating profit or economic profit. Its ownership and operational structure align with the general definition of a business, which includes components such as the enterprise itself, economic activity, the business sector, property, and human capital. ### Historical Origins and Timeline The entity was established in 1923, marking its entry into the Mexican market. This inception date places the organization's history within the early 20th-century development of the pharmaceutical industry in Mexico. While the specific founding events of 1923 are not detailed in the source, the date serves as the definitive starting point for its existence as a legal and commercial entity. The organization has maintained its status as a business entity from its inception to the present day, operating under the umbrella of its parent company, Novo Nordisk. ### Geographic Presence and Headquarters The organization is headquartered in Mexico City, which serves as the capital and largest city of Mexico. Mexico City is located in North America at an elevation of 2,240 meters, with specific coordinates of 19.438746 latitude and -99.205559 longitude for the Novo Nordisk (Mexico) headquarters. The city itself is a federative entity with a population of 9,209,944 as of the 2020 census. As the political, cultural, and economic center of the nation, Mexico City provides the strategic environment for the organization's operations. The country of operation is Mexico, a sovereign state with a population of approximately 132 million and an area of 1,972,550 square kilometers. ### Digital Identifiers and Academic Presence Novo Nordisk (Mexico) is indexed across multiple global knowledge and research systems, ensuring its visibility in academic and professional contexts. * **Research Organization Registry (ROR):** The organization holds the ID 03w48ac58. * **Global Research Identifier Database (GRID):** It is assigned the ID grid.508745.b. * **Scilit:** The entity is listed with the Scilit Organization ID 98347. * **Wikidata:** It is described as an "organization" and is linked to the parent entity Novo Nordisk. These identifiers allow for precise data linking in bibliographic databases, research repositories, and knowledge graphs, facilitating the tracking of the organization's contributions and activities. ### Corporate Structure and Relationships The entity is explicitly identified as "part of" the larger organization, Novo Nordisk. This relationship defines its status as a subsidiary or regional branch within the global corporate structure. As a business, it falls under the broader category of organizations that are legally classified as juridical persons. The organization's structure includes the standard components of a business: enterprise, economic activity, business sector, property, and human capital. It operates within the Mexican legal framework, which recognizes it as a commercial entity capable of engaging in professional and industrial activities. ### Operational Context in Mexico Operating within Mexico, the organization benefits from the country's status as a federal republic with a presidential system. Mexico's economy, the 15th-largest globally, provides a robust market for pharmaceutical and professional services. The country's official language is Spanish, with 68 recognized indigenous languages, and its currency is the Mexican peso. The organization's presence in Mexico City, a hub for international trade and diplomacy, positions it within a network of global connections. Mexico City itself is a member of the Creative Cities Network and the League of Historical Cities, adding to the cultural and economic prestige of the location where Novo Nordisk (Mexico) is based. ## References 1. GRID release 2020-10-06 2. ROR Data Dump 6.0 (October 2020)